Get startedLog in
    Picture of Egetis Therapeutics AB (publ) logo

    EGTX — Egetis Therapeutics AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapMomentum Trap
    All News

    Brief: Egetis Decides To Explore RTH-Beta As Next Indication For Tiratricol (Emcitate)

    Picture of Egetis Therapeutics AB (publ) logoEgetis Therapeutics AB (publ)
    04/12/2024 07:04
    Dec 4 (Reuters) - Egetis Therapeutics AB (publ)
 EGTX.ST :
    * EGETIS HAS DECIDED TO EXPLORE RTH-BETA AS THE NEXT
INDICATION
FOR TIRATRICOL (EMCITATE®)

Source text:  ID:nMFNncnc4 
Further company coverage:  EGTX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Egetis Therapeutics AB (publ)

    See all news